Takumi Nagata

Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models

M. Suzuki, Minako Takeda, A Kito et al. · Nutrition and Diabetes · 2014 · 97 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Tofogliflozin, a novel sodium–glucose co‐transporter 2 inhibitor, improves renal and pancreatic function in <i>db/db</i> mice

Takumi Nagata, Taku Fukuzawa, Minako Takeda et al. · British Journal of Pharmacology · 2013 · 87 citations · Full text

Medicine, Endocrinology, Pharmacology +17

<i>Sox17</i> haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice

Mami Uemura, Aisa Ozawa, Takumi Nagata et al. · Development · 2013 · 69 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats

Takumi Nagata, Masanori Fukazawa, Kiyofumi Honda et al. · American Journal of Physiology-Endocrinology and Metabolism · 2012 · 44 citations

Medicine, Pharmacology, Pharmacotherapy +15

Age-related changes of male mouse submandibular gland: a morphometric and radioautographic study.

S Chen, Feng Gao, A. Kotani et al. · PubMed · 1995 · 23 citations

Life Sciences, Anatomy, Developmental Biology +17